UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Annals of oncology, 2014-06, Vol.25 (6), p.1128-1136

2014

Volltextzugriff (PDF)

Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation

Familial cancer, 2019-01, Vol.18 (1), p.1-8

2019

Volltextzugriff (PDF)

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Familial cancer, 2018, Vol.17 (1), p.5-14

2018

Volltextzugriff (PDF)

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Annals of oncology, 2006-01, Vol.17 (1), p.85-92

2006

Volltextzugriff (PDF)

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

Cancer, 2005-12, Vol.104 (12), p.2792-2797

2005

Volltextzugriff (PDF)

French version of FACT-G: validation and comparison with other cancer-specific instruments

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2243-2252

2004

Volltextzugriff (PDF)

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Critical reviews in oncology/hematology, 2010-10, Vol.76 (1), p.71-78

2010

Volltextzugriff (PDF)

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

Annals of oncology, 2001-03, Vol.12 (3), p.397-404

2001

Volltextzugriff (PDF)

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Familial cancer, 2012-06, Vol.11 (2), p.269-278

2012

Volltextzugriff (PDF)

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Annals of oncology, 2006-01, Vol.17 (1), p.65-73

2006

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i7-i9

2005

Volltextzugriff (PDF)

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Volltextzugriff (PDF)

Cancer genetics: estimation of the needs of the population in France for the next ten years

Bulletin du cancer, 2009-09, Vol.96 (9), p.875

2009

Volltextzugriff (PDF)

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

British journal of cancer, 2003-08, Vol.89 (S1), p.S17-S31

2003

Volltextzugriff (PDF)

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

OncoTargets and therapy, 2016-01, Vol.9, p.6689-6693

2016

Volltextzugriff (PDF)

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

European journal of cancer (1990), 2012-01, Vol.48 (1), p.101-107

2012

Volltextzugriff (PDF)

Mutation analysis of PALB2 gene in French breast cancer families

Breast cancer research and treatment, 2015-12, Vol.154 (3), p.463-471

2015

Volltextzugriff (PDF)

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

International journal of radiation oncology, biology, physics, 1994-07, Vol.29 (4), p.673-679

1994

Volltextzugriff (PDF)

Quality of life in long-term survivors of oropharynx carcinoma

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.742-751

2002

Volltextzugriff (PDF)

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1056-1065

2004

Volltextzugriff (PDF)

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Gynecologic oncology, 1999-11, Vol.75 (2), p.187-193

1999

Volltextzugriff (PDF)

Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer

International journal of radiation oncology, biology, physics, 1998-12, Vol.42 (5), p.935-941

1998

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Annals of oncology, 2001-08, Vol.12 (8), p.1047-1048

ESMO

2001

Volltextzugriff (PDF)

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

European journal of cancer (1990), 2001-06, Vol.37 (9), p.1132-1140

2001

Volltextzugriff (PDF)

Randomized Trial Comparing Six Versus Three Cycles of Epirubicin-Based Adjuvant Chemotherapy in Premenopausal, Node-Positive Breast Cancer Patients: 10-Year Follow-Up Results of the French Adjuvant Study Group 01 Trial

Journal of clinical oncology, 2003-01, Vol.21 (2), p.298-305

2003

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaSciences Medicales

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(53)

Sprache

Englisch
(49)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(50)
Female
(44)
Middle Aged
(38)
Aged
(31)
Adult
(30)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Male
(25)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Tumors
(18)
Aged, 80 And Over
(17)
Pharmacology. Drug Treatments
(14)
Breast Cancer
(13)
Retrospective Studies
(13)
Brachytherapy
(12)
Carcinoma, Squamous Cell - Radiotherapy
(12)
France
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

French version of FACT-G: validation and comparison with other cancer-specific instruments

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Cancer genetics: estimation of the needs of the population in France for the next ten years

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

Mutation analysis of PALB2 gene in French breast cancer families

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

Quality of life in long-term survivors of oropharynx carcinoma

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

Randomized Trial Comparing Six Versus Three Cycles of Epirubicin-Based Adjuvant Chemotherapy in Premenopausal, Node-Positive Breast Cancer Patients: 10-Year Follow-Up Results of the French Adjuvant Study Group 01 Trial

Aktive Filter

Suchergebnisse filtern